Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale Director sold 15,174 shares at an average $46.17 ($700,515)
  2. 4 Open-market sale Director sold 11,670 shares at $43.95 ($512,840)
  3. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $43.67 ($218,346)
  4. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $45.29 ($62,274)
  5. 4 Open-market sale Director sold 11,670 shares at $44.56 ($520,033)
  6. 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $41.49 ($414,874)
  7. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $42.51 ($58,451)
  8. 4 Grant or award Director acquired 3,374 shares (grant or award)
  9. 4 Grant or award Director acquired 3,374 shares (grant or award)
  10. 4 Grant or award Director acquired 3,374 shares (grant or award)
  11. 4 Grant or award Director acquired 3,374 shares (grant or award)
  12. 4 Grant or award Director acquired 3,374 shares (grant or award)
  13. 4 Grant or award Director acquired 3,374 shares (grant or award)
  14. 4 Grant or award Director acquired 3,374 shares (grant or award)
  15. 4 Grant or award Director acquired 3,374 shares (grant or award)
  16. 4 Grant or award Director acquired 3,374 shares (grant or award)
  17. 4 Grant or award Director acquired 3,374 shares (grant or award)
  18. 4 Open-market sale Director sold 11,670 shares at an average $44.50 ($519,351)
  19. 4 Open-market sale Director sold 10,000 shares at $43.73 ($437,275)
  20. 4 Open-market sale Director sold 15,174 shares at an average $43.80 ($664,601)

Page 17 of 25 · 491 filings